← Back to companies
United States · Medical / biomanufacturing robotics · privateThis company was auto-listed from our component database and has not yet had a full editorial review. The facts below come from supplier and product data; treat as unverified until reviewed.
Summary
Physical-AI robotic clusters for GMP biologics manufacturing (cell/gene therapy, antibodies, viral vectors, mRNA) owned and operated inside pharma facilities. Claims 74% lower cost/dose and up to 100x throughput vs manual (company).
Key facts
Headquarters
San Francisco, California
Founded
2016
Role
builder
Category
Medical
Sector
Medical / biomanufacturing robotics
Status
private
Funding
$75M Series B (Oct 2026) led by NantWorks / Patrick Soon-Shiong; total >$100M
Robots tracked — ranked across 2 companies
Peers — same category & country
ISPeers — same category, other markets
CS
United Kingdom
South KoreaCapital
Funding
$75M Series B (Oct 2026) led by NantWorks / Patrick Soon-Shiong; total >$100M
Status
private
Investors
Primary-source investor lists stay on the interactive company profile. This page does not add investors that are not on the company record.
Figures as recorded by behindrobotics.com from company announcements, filings and market reporting. Verify before citing.